SCHEMBL1668550

SCHEMBL1668550

OC12CCCCC1OC1(O)CCCCC1O2

nearest known ligand 0.41

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
HSD11B1 P28845 1/20 0.33
MET P08581 1/20 0.33
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1262406 1.00
SCHEMBL10816126 1.00
SCHEMBL9019381 0.92
SCHEMBL9808495 0.92
SCHEMBL9647565 0.82 LMNA (0.35) LMNATSHR
SCHEMBL12796396 0.78 LMNA (0.34) LMNATSHRMET
SCHEMBL12796387 0.77 LMNA (0.33) LMNATSHRMET
SCHEMBL21119422 0.72 KDM4E (0.31)
SCHEMBL12796383 0.70 MET (0.36) LMNATSHRMET
SCHEMBL12796478 0.69 KMT2A (0.36) LMNATSHRMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4280882-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2023-11-29 EP claimed
WO-2022159439-A2 MATERIALS AND METHODS FOR EXTENDING SHELF-LIFE OF FOODS JP LABORATORIES, INC. (US) 2022-07-28 WO claimed
EP-3365898-B1 USE OF HYDROXYIMINOALCANI ACID AS ANTI-NITRIC AGENTS IN REDUCTIVE REEXTRACTION PROCESSES FOR PLUTONIUM COMMISSARIAT ENERGIE ATOMIQUE (FR) 2019-11-13 EP disclosed
US-10354765-B2 Use of hydroxyiminoalkanoic acids as anti-nitrous agents in operations of reductive stripping of plutonium Commissariat à l'énergie atomique et aux energies alternatives (FR) 2019-07-16 US disclosed
EP-2279291-B1 COFERONS AND METHODS OF MAKING AND USING THEM UNIV CORNELL (US) 2019-07-03 EP disclosed
EP-2279291-B1 COFERONS AND METHODS OF MAKING AND USING THEM UNIV CORNELL (US) 2019-07-03 EP disclosed
US-9943603-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2018-04-17 US disclosed
US-9943603-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2018-04-17 US disclosed
US-9943603-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2018-04-17 US disclosed
US-9771345-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2017-09-26 US disclosed
US-9771345-B2 Coferons and methods of making and using them CORNELL UNIVERSITY (US) 2017-09-26 US disclosed
US-20110263688-A1 COFERONS AND METHODS OF MAKING AND USING THEM PURDUE RESEARCH FOUNDATION (US) 2011-10-27 US disclosed
WO-2011043817-A1 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2011-04-14 WO disclosed
US-20100120730-A1 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS NYCOMED GMBH (DE) 2010-05-13 US disclosed
US-20100120730-A1 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS NYCOMED GMBH (DE) 2010-05-13 US disclosed
WO-2010015589-A1 BENZYL-SUBSTITUTED TETRACYCLIC HETEROCYCLIC COMPOUNDS AS PDE5 INHIBITORS NYCOMED GMBH (DE) 2010-02-11 WO disclosed
WO-2010015586-A2 2,3,4,7-TETRAHYDRO-INDOLO[2,3-C]QUINOLINE COMPOUNDS NYCOMED GMBH (DE) 2010-02-11 WO disclosed
WO-2009126290-A2 COFERONS AND METHODS OF MAKING AND USING THEM CORNELL UNIVERSITY (US) 2009-10-15 WO disclosed
WO-2008095835-A1 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2, 3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS NYCOMED GMBH (DE) 2008-08-14 WO disclosed
EP-1953159-A1 6-Benzyl-2,3,4,7-tetrahydro-indolo[2,3-c]quinoline compounds useful as PDE5 inhibitors Nycomed GmbH (DE) 2008-08-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263688-A1 COFERONS AND METHODS OF MAKING AND USING THEM MYOF, FTH1, TFRC LMNA 471/4885TSHR 2519/4885HSD11B1 4290/4885
US-20100120730-A1 6-BENZYL-2,3,4,7-TETRAHYDRO-INDOLO [2,3-C] QUINOLINE COMPOUNDS USEFUL AS PDE5 INHIBITORS PDE5A, PDE3A, PDE2A LMNA 2585/4885TSHR 3186/4885HSD11B1 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.